nodes	percent_of_prediction	percent_of_DWPC	metapath
Iopamidol—Blindness cortical—Cyclosporine—focal segmental glomerulosclerosis	0.193	0.193	CcSEcCtD
Iopamidol—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0383	0.0383	CcSEcCtD
Iopamidol—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0377	0.0377	CcSEcCtD
Iopamidol—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0262	0.0262	CcSEcCtD
Iopamidol—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.0232	0.0232	CcSEcCtD
Iopamidol—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0232	0.0232	CcSEcCtD
Iopamidol—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.0227	0.0227	CcSEcCtD
Iopamidol—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0208	0.0208	CcSEcCtD
Iopamidol—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0203	0.0203	CcSEcCtD
Iopamidol—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.0198	0.0198	CcSEcCtD
Iopamidol—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0192	0.0192	CcSEcCtD
Iopamidol—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0167	0.0167	CcSEcCtD
Iopamidol—Coma—Cyclosporine—focal segmental glomerulosclerosis	0.0167	0.0167	CcSEcCtD
Iopamidol—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0148	CcSEcCtD
Iopamidol—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.0148	0.0148	CcSEcCtD
Iopamidol—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Iopamidol—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0141	CcSEcCtD
Iopamidol—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.014	0.014	CcSEcCtD
Iopamidol—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.014	0.014	CcSEcCtD
Iopamidol—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0137	CcSEcCtD
Iopamidol—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.0136	0.0136	CcSEcCtD
Iopamidol—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0119	CcSEcCtD
Iopamidol—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0117	CcSEcCtD
Iopamidol—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Iopamidol—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0111	CcSEcCtD
Iopamidol—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0101	0.0101	CcSEcCtD
Iopamidol—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Iopamidol—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Iopamidol—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.01	CcSEcCtD
Iopamidol—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00991	0.00991	CcSEcCtD
Iopamidol—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00972	0.00972	CcSEcCtD
Iopamidol—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.0092	0.0092	CcSEcCtD
Iopamidol—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00918	0.00918	CcSEcCtD
Iopamidol—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00916	0.00916	CcSEcCtD
Iopamidol—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00911	0.00911	CcSEcCtD
Iopamidol—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00882	0.00882	CcSEcCtD
Iopamidol—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00854	0.00854	CcSEcCtD
Iopamidol—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.0085	0.0085	CcSEcCtD
Iopamidol—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00822	0.00822	CcSEcCtD
Iopamidol—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00818	0.00818	CcSEcCtD
Iopamidol—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.00781	CcSEcCtD
Iopamidol—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00766	0.00766	CcSEcCtD
Iopamidol—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00747	0.00747	CcSEcCtD
Iopamidol—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0074	0.0074	CcSEcCtD
Iopamidol—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.00732	CcSEcCtD
Iopamidol—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00719	0.00719	CcSEcCtD
Iopamidol—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00696	0.00696	CcSEcCtD
Iopamidol—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00691	0.00691	CcSEcCtD
Iopamidol—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00688	0.00688	CcSEcCtD
Iopamidol—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00679	0.00679	CcSEcCtD
Iopamidol—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00679	0.00679	CcSEcCtD
Iopamidol—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00676	0.00676	CcSEcCtD
Iopamidol—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0067	0.0067	CcSEcCtD
Iopamidol—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00656	0.00656	CcSEcCtD
Iopamidol—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.0065	0.0065	CcSEcCtD
Iopamidol—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00646	0.00646	CcSEcCtD
Iopamidol—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00629	0.00629	CcSEcCtD
Iopamidol—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0062	0.0062	CcSEcCtD
Iopamidol—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00593	0.00593	CcSEcCtD
Iopamidol—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00584	0.00584	CcSEcCtD
Iopamidol—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0058	CcSEcCtD
Iopamidol—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00573	0.00573	CcSEcCtD
Iopamidol—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00565	0.00565	CcSEcCtD
Iopamidol—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00561	0.00561	CcSEcCtD
Iopamidol—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00556	0.00556	CcSEcCtD
Iopamidol—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00536	0.00536	CcSEcCtD
Iopamidol—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00517	0.00517	CcSEcCtD
Iopamidol—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00514	CcSEcCtD
Iopamidol—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00514	0.00514	CcSEcCtD
Iopamidol—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.00467	CcSEcCtD
Iopamidol—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.0046	CcSEcCtD
Iopamidol—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.00445	CcSEcCtD
Iopamidol—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.0043	CcSEcCtD
Iopamidol—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.00414	CcSEcCtD
Iopamidol—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.0041	CcSEcCtD
Iopamidol—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0041	0.0041	CcSEcCtD
Iopamidol—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.00408	CcSEcCtD
Iopamidol—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00386	CcSEcCtD
